Blooduct Medical
Arterial Rupture Bypass Device for Patient Stabilization
Non Active, Dec 2019 ceased to operate
Company Overview
Snapshot
Founded in April 2016 by Ifat Korek-Abadi and Yoav Pikkel, Blooduct Medical operates with 1–10 employees. The company ceased operations in December 2019.
Business overview
Blooduct Medical develops a lifesaving patient-stabilization device designed to bypass arterial ruptures. This generic, temporary endovascular device is intended for use in hospital trauma bays, providing critical time for physicians to assess patients with damage to multiple organs and determine further treatment or transfer. The company operates within the Digital Health and Medical Technologies sector, focusing on medical devices and equipment for hospitals and healthcare providers globally.
Company Intelligence Q&A
- What is Blooduct Medical's primary focus?
- Blooduct Medical develops a temporary endovascular device to bypass arterial ruptures, aiming to stabilize patients in trauma situations and provide critical time for medical assessment.
- When was Blooduct Medical founded?
- Blooduct Medical was founded in April 2016.
- Who are the founders of Blooduct Medical?
- Blooduct Medical was co-founded by Ifat Korek-Abadi and Yoav Pikkel.
- What is the operational status of Blooduct Medical?
- Blooduct Medical ceased to operate in December 2019.
- In which sector does Blooduct Medical operate?
- Blooduct Medical operates in the Digital Health and Medical Technologies sector, specifically focusing on medical devices and life support.